Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database

Author: Østergaard M.   Unkerskov J.   Linde L.   Krogh N. S.   Ravn T.   Ringsdal V. S.   Petri A.   Andersen L. S.   Tarp U.   Hansen A.   Hjardem E.   Hetland M. L.  

Publisher: Informa Healthcare

ISSN: 0300-9742

Source: Scandinavian Journal of Rheumatology, Vol.36, Iss.2, 2007-01, pp. : 151-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content